Navigation Links
Scripps research scientists shed light on potential treatment for Gaucher's disease
Date:5/9/2010

ng of many proteins takes place.

A Genetic Disease

Gaucher's disease is the most common genetic disease among the Ashkenazi Jewish population of Eastern European ancestry. Symptoms include bruising easily due to low blood platelets, enlargement of the liver and spleen, and fatigue due to anemia. The disease also causes cells in the bone marrow to become engorged with a fatty storage material, which may lead to bone lesions, weakening the skeleton, sometimes resulting in painful fractures. In some instances, the disease also impairs the function of the lungs or the central nervous system.

Gaucher's disease (named after the French dermatologist Phillipe Gaucher, who first described the condition in 1882) is caused by mutations in a person's beta-glucosidase genes, and these defects corrupt his or her beta-glucosidase enzyme. Some of these corrupted enzymes cannot fold properly into their correct three-dimensional structure because they are unstable in the neutral pH environment of the endoplasmic reticulum. The corrupted, mutant enzymes are often degraded by a process known as endoplasmic reticulum-associated degradation, and fail to reach their destinationanother subcellular compartment called the lysosome, where they normally break down a fatty substance called glucosylceramides. When the beta-glucosidase concentration and/or enzymatic activity in the lysosome are too low, glucosylceramides accumulate, causing the symptoms of Gaucher's disease.

The current approaches for treating Gaucher's disease (and a few of the 40 or so other lysosomal storage disorders) involve replacing the deficient enzyme with an enzyme that is made using recombinant engineering and then is injected into the patient. Enzyme replacement therapy is an effective way to restore many patients to good health, but it has drawbacks. The enzyme has to be infused intravenously or through a surgically implanted catheterusually in a doctor's officea process tha
'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Scripps Research team provides groundbreaking new understanding of stem cells
2. New Scripps Research and GNF study helps explain how we can sense temperatures
3. Scripps Research scientists reveal how genetic mutations may cause type 1 diabetes
4. New nano-tool synthesized at Scripps Research Institute
5. Scripps Research scientists solve mystery of fragile stem cells
6. Scripps research team reveals how an old drug could have a new use for treating river blindness
7. Scripps Research scientists find two compounds that lay the foundation for a new class of AIDS drug
8. Scripps Research scientists create new way to screen libraries of 10 million or more compounds
9. Scripps Research team wins global race to achieve landmark synthesis of perplexing natural product
10. Scripps Florida scientists show lifeless prions capable of evolutionary change and adaptation
11. Scripps research team develops technique to determine ethnic origin of stem cell lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2014)... discovered a new kind of stem cell that can become ... blood vessels, according to a study published today in the ... a cell type contradicts current theory on how organs arise ... to origins of, and future treatment for, liver cancer., Thanks ... a complex being made up of more than 200 cell ...
(Date:10/14/2014)... Scientists from The Scripps Research Institute (TSRI) have been ... (NIH) to lead an investigation of Lassa fever virus, ... The study aims to understand how Lassa fever virus ... survive the inflection. , "The ultimate goal is ... Lassa fever virus causes disease and develop new treatments ...
(Date:10/14/2014)... team of researchers, led by the Chinese Academy of ... Nature Genetics a brief genomic history of tomato ... tomato plant. , The C.M. Rick Tomato Genetics Resource ... this study by providing seed of both cultivated tomato ... builds on the first tomato genome sequence completed just ...
Breaking Biology News(10 mins):Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
... Sathyanaryanan Puthanveettil, an assistant professor on the Florida ... a pair of notable grants to study a critical ... receive $225,000 over three years from the prestigious Whitehall ... a motor protein called kinesin. In this study, he ...
... most commonly diagnosed cancer in the United States and often ... on ways to improve their understanding of the disease. ... at the San Diego Marriott Marquis & Marina during Jan. ... of Lung Cancer: Biology, Therapy and Personalized Medicine. ...
... WASHINGTON -- The draft 10-year strategic plan for ... shapes and coordinates climate and related global environmental change ... federal government -- is "evolving in the right direction," ... says a new report from the National Research Council. ...
Cached Biology News:Scripps Research Scientist wins pair of grants to study critical component of memory 2Lung cancer conference to focus on new diagnostic techniques, potential treatments 2New report reviews plan for US Global Change Research Program 2
(Date:10/22/2014)... Currently offering a comprehensive portfolio ... Weighing, Rice Lake, and Ohaus, Pipette.com has added ... Sartorius CPA Semi-Micro Balance is ideal for lab ... user-friendly laboratory balance. , Sartorius is a global ... balances are well known for their high performance, ...
(Date:10/22/2014)... 2014   Synthetic Biologics, Inc. (NYSE MKT: ... serious infections and diseases, announced today that the U.S. ... Allowance for a composition of matter patent application that ... program, SYN-004. This is Synthetic Biologics, first allowed patent ... adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... Genencor,s Senior Management Team, ROCHESTER, N.Y., Oct. ... announced that Dr. Glenn E. Nedwin will join ... effective Oct. 1, 2007. As a,member of the ... the,division,s activities in Grain Processing (which includes current ...
... CEO Glenn A. Oclassen to Join Sleep Experts in Panel Hosted by ... ... 1 Transcept Pharmaceuticals,Inc. today announced that Glenn A. Oclassen, President and ... the Natixis Bleichroeder "Hidden Gems" Healthcare Conference. Date: Monday, ...
... BRUSSELS, October 1 Austria now has the ... 2007 Euro,Health Consumer Index (EHCI). The EHCI compares ... Norway and Switzerland, from a,consumer-friendly point of view, ... 2005 winners the Netherlands, with 2006 winner,France in ...
Cached Biology Technology:Genencor Appoints New Executive Vice President - Technical Enzymes 2Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel 2European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform 2
Polyclonal Antibody to HADHB...
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: